Oxigene

Oxigene Receives Fast Track Designation From U.S. FDA for CA4P
Yahoo
Wed, 03/30/16 - 10:15 am
Oxigene
fast track
FDA
CA4P
ovarian cancer
platinum-resistant ovarian cancer
Oxigene's pancreatic cancer treatments granted orphan drug status in Europe
Marketwatch
Sat, 03/26/16 - 01:01 pm
Oxigene
pancreatic cancer
orphan drugs
CA4P
Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data
TheStreet.com
Wed, 11/12/14 - 08:38 am
Oxigene
ovarian cancer
fosbretabulin
Avastin
8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Tue, 04/8/14 - 09:46 am
Zohydro
Zogenix
Zybrestat
Oxigene
Arikayce
Insmed
obeticholic acid
Intercept Pharmaceuticals
Oxigene shares surge after positive clinical trial
Marketwatch
Wed, 03/12/14 - 10:12 am
Oxigene
ovarian cancer
Zybrestat
OXiGENE's Oncology Drugs Have Run Their Course
Seeking Alpha
Wed, 05/1/13 - 11:01 am
Oxigene
oncology
Risk Vs. Reward: 2 Biotech Stocks I'm Considering In The Wake Of Recent Developments
Seeking Alpha
Sat, 11/24/12 - 11:36 am
Oxigene
Astex
4 Pharmaceutical Companies Moving On News
Seeking Alpha
Mon, 08/6/12 - 11:13 am
Oxigene
Biostar Pharmaceuticals
Pluristem Therapeutics
Cellceutix
BIO CEO Conference Live Blog
TheStreet.com
Mon, 02/13/12 - 10:30 am
BIO CEO Conference
Celsion
Cyclacel
Navidea Biopharmaceuticals
Chelsea Therapeutics
Titan
Galena Biopharma
Oxigene
You Should Have Seen These Biotech Failures Coming
Motley Fool
Sat, 11/5/11 - 02:44 pm
Oxigene
Rexahn
Oxigene Headed Back Down On Disappointing Zybrestat Results
Seeking Alpha
Fri, 11/4/11 - 09:20 am
Zybrestat
Oxigene
non-small cell lung cancer
Why Speculators Are Buzzing About OxiGENE
Seeking Alpha
Mon, 10/31/11 - 11:30 am
Oxigene
Zybrestat
OXiGENE and Neoprobe Reawaken Investor Interest in Biotechnology Industry
Fri, 10/21/11 - 06:37 pm
Oxigene
Neoprobe
investment
biotech
ASCO studies shake up drug stocks
Marketwatch
Tue, 06/7/11 - 06:22 pm
ASCO
drug stocks
Sunesis
Exelixis
Bayer
Oxigene
Regeneron
EntreMed
Oxigene soars on Nasdaq update
Marketwatch
Mon, 06/6/11 - 10:20 am
Oxigene
NASDAQ
OXiGENE Reports Encouraging Data From Phase 2 Trial of ZYBRESTAT(TM) in Non-small Cell Lung Cancer
Yahoo/Globe NewsWire
Sun, 06/5/11 - 10:07 am
Oxigene
Zybrestat
non-small cell lung cancer
ASCO: Cancer Stock Winners, Losers
TheStreet.com
Thu, 05/19/11 - 01:56 pm
ASCO
Vical
Oxigene
Agenus
Ariad Pharmaceuticals
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
ASCO
Medivation
Exelixis
Dendreon
Bristol-Myers Squibb
Roche
Curis
Celgene
Sanofi
Ariad Pharmaceuticals
Merck
Incyte
Novartis
YM BioSciences
Pfizer
Aveo Pharmaceutical
ONYX Pharmaceuticals
Amgen
Synta
Vical
Oxigene
Cell Therapeutics
Oncothyreon
ZYBRESTAT(TM) (CA4P) Improves Overall Survival in a Phase 2/3 Trial (FACT Study) of Patients With Anaplastic Thyroid Cancer (ATC)
Yahoo/Globe NewsWire
Sun, 09/12/10 - 11:22 am
Zybrestat
Oxigene
thyroid cancer
OXiGENE Reports Encouraging Safety and Efficacy Data from Ongoing Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2010 ASCO Annual Meeting
Yahoo/Globe NewsWire
Sun, 06/6/10 - 10:53 am
Oxigene
non-small cell lung cancer
Zybrestat

Pages